Maduike Ezeibe Claims He Cures HIV/AIDS

NIGERIAN PROFESSOR PRODUCES ANTIVIRT, ANTI

VIRAL DRUG THAT CURES HIV AIDS IN 2 MONTHS

Nigerian Professor Produces Antivirt, An Anti Viral

Drug For Treating HIV AIDS. Despite doubts in

some quarters about the authenticity of his claims,

Professor Maduike Ezeibe of Michael Okpara

University of Agriculture Umudike (MOUAU), Abia

State, has insisted that his recent therapy

for the dreaded HIV and AIDS is real and

effective.

The discovery of the therapy, Ezeibe said, was a

major scientific breakthrough in the search for a

cure to the global pandemic.

He said after 19 years of hard work, he was able

to discover the therapy and his research was

eventually published in the British Journal of

Medicine & Medical Research.

The Professor of Veterinary Medicine, who obtained

his first degree in same discipline at the University

of Nigeria Nsukka in 1986, Masters in Ruminant

Medicine, and doctorate degree in Canine Medicine

all in UNN, said he moved to MOUAU on leave of

absence.

Speaking with Southern City News in his office, he

said his research into the therapy known as

‘Antivirt’ (Anti-Viral Therapy), dated back to 1994

when he took the challenge to be part of the global

solution to the HIV/AIDS scourge ravaging

humanity.

Ezeibe said his work had been published by the

American-based medical journal known as The

Health.

He said he decided to publish his research work on

the therapy so as to prove anyone who would doubt

that a black man could develop HIV/AIDS cure,

wrong.

He boasted that the experiment remained

authentic and verifiable in any part of the world.

According to him, two essential minerals – aluminum

silicate (kaolin) and magnesium silicate, used in the

production of the therapy, have large deposits in

Umuahia and parts of Abia State.

This, he said, would make the therapy cheaper and

more affordable than the old anti-retroviral

therapy.

He added that the therapy would take an average

of two to three months to cure HIV/AIDS patient.